Total Funding
69
71
Total FundingSeries A raised
Growth Score
-13 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
4712
Altos Labs focuses on cellular rejuvenation programming to restore cell health and resilience, to reverse disease to transform medicine.
- Herbert Skip Virgin: Chief Medical Officer and Head of the Altos Institute of MedicinePast Role: Vir Biotechnology, EVP, Research and Chief Scientific Officer
- Joan Mannick: Senior Vice President, Chief Medical Officer and Head of Product DevelopmentPast Role: Tornado Therapeutics, Co-Founder and Chief Executive Officer
About the Company
Altos Labs is a biotechnology company focused on cellular rejuvenation programming to restore cell health and resilience, with the goal of reversing disease to transform medicine. The company comprises a community of leading scientists, clinicians, and leaders from both academia and industry working together towards this common mission. Altos has
operations in the San Francisco Bay Area and San Diego, and in Cambridge, UK, with significant collaborations in Japan.
